279 related articles for article (PubMed ID: 18006502)
1. Inhibition of Raf-1 alters multiple downstream pathways to induce pancreatic beta-cell apoptosis.
Alejandro EU; Johnson JD
J Biol Chem; 2008 Jan; 283(4):2407-17. PubMed ID: 18006502
[TBL] [Abstract][Full Text] [Related]
2. Acute insulin signaling in pancreatic beta-cells is mediated by multiple Raf-1 dependent pathways.
Alejandro EU; Kalynyak TB; Taghizadeh F; Gwiazda KS; Rawstron EK; Jacob KJ; Johnson JD
Endocrinology; 2010 Feb; 151(2):502-12. PubMed ID: 20056832
[TBL] [Abstract][Full Text] [Related]
3. Transient hypoxia induces ERK-dependent anti-apoptotic cell survival in endothelial cells.
Härtel FV; Holl M; Arshad M; Aslam M; Gündüz D; Weyand M; Micoogullari M; Abdallah Y; Piper HM; Noll T
Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1501-9. PubMed ID: 20200209
[TBL] [Abstract][Full Text] [Related]
4. EGF regulates survivin stability through the Raf-1/ERK pathway in insulin-secreting pancreatic β-cells.
Wang H; Gambosova K; Cooper ZA; Holloway MP; Kassai A; Izquierdo D; Cleveland K; Boney CM; Altura RA
BMC Mol Biol; 2010 Aug; 11():66. PubMed ID: 20807437
[TBL] [Abstract][Full Text] [Related]
5. Fractalkine stimulates angiogenesis by activating the Raf-1/MEK/ERK- and PI3K/Akt/eNOS-dependent signal pathways.
Lee SJ; Namkoong S; Kim YM; Kim CK; Lee H; Ha KS; Chung HT; Kwon YG; Kim YM
Am J Physiol Heart Circ Physiol; 2006 Dec; 291(6):H2836-46. PubMed ID: 16877565
[TBL] [Abstract][Full Text] [Related]
6. Effects of piceatannol and pterostilbene against β-amyloid-induced apoptosis on the PI3K/Akt/Bad signaling pathway in PC12 cells.
Fu Z; Yang J; Wei Y; Li J
Food Funct; 2016 Feb; 7(2):1014-23. PubMed ID: 26757883
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor 1 inhibits extracellular signal-regulated kinase to promote neuronal survival via the phosphatidylinositol 3-kinase/protein kinase A/c-Raf pathway.
Subramaniam S; Shahani N; Strelau J; Laliberté C; Brandt R; Kaplan D; Unsicker K
J Neurosci; 2005 Mar; 25(11):2838-52. PubMed ID: 15772344
[TBL] [Abstract][Full Text] [Related]
8. ERK- and Akt-dependent neuroprotection by erythropoietin (EPO) against glyoxal-AGEs via modulation of Bcl-xL, Bax, and BAD.
Shen J; Wu Y; Xu JY; Zhang J; Sinclair SH; Yanoff M; Xu G; Li W; Xu GT
Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):35-46. PubMed ID: 19628748
[TBL] [Abstract][Full Text] [Related]
9. Apoptosis suppression by Raf-1 and MEK1 requires MEK- and phosphatidylinositol 3-kinase-dependent signals.
von Gise A; Lorenz P; Wellbrock C; Hemmings B; Berberich-Siebelt F; Rapp UR; Troppmair J
Mol Cell Biol; 2001 Apr; 21(7):2324-36. PubMed ID: 11259582
[TBL] [Abstract][Full Text] [Related]
10. B-Raf inhibits programmed cell death downstream of cytochrome c release from mitochondria by activating the MEK/Erk pathway.
Erhardt P; Schremser EJ; Cooper GM
Mol Cell Biol; 1999 Aug; 19(8):5308-15. PubMed ID: 10409722
[TBL] [Abstract][Full Text] [Related]
11. Activation of the RAF/mitogen-activated protein/extracellular signal-regulated kinase kinase/extracellular signal-regulated kinase pathway mediates apoptosis induced by chelerythrine in osteosarcoma.
Yang R; Piperdi S; Gorlick R
Clin Cancer Res; 2008 Oct; 14(20):6396-404. PubMed ID: 18927278
[TBL] [Abstract][Full Text] [Related]
12. The ghrelin gene products and exendin-4 promote survival of human pancreatic islet endothelial cells in hyperglycaemic conditions, through phosphoinositide 3-kinase/Akt, extracellular signal-related kinase (ERK)1/2 and cAMP/protein kinase A (PKA) signalling pathways.
Favaro E; Granata R; Miceli I; Baragli A; Settanni F; Cavallo Perin P; Ghigo E; Camussi G; Zanone MM
Diabetologia; 2012 Apr; 55(4):1058-70. PubMed ID: 22231124
[TBL] [Abstract][Full Text] [Related]
13. Bcl-2 protects endothelial cells against gamma-radiation via a Raf-MEK-ERK-survivin signaling pathway that is independent of cytochrome c release.
Kumar P; Coltas IK; Kumar B; Chepeha DB; Bradford CR; Polverini PJ
Cancer Res; 2007 Feb; 67(3):1193-202. PubMed ID: 17283155
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of phosphorylation of BAD and Raf-1 by Akt sensitizes human ovarian cancer cells to paclitaxel.
Mabuchi S; Ohmichi M; Kimura A; Hisamoto K; Hayakawa J; Nishio Y; Adachi K; Takahashi K; Arimoto-Ishida E; Nakatsuji Y; Tasaka K; Murata Y
J Biol Chem; 2002 Sep; 277(36):33490-500. PubMed ID: 12087097
[TBL] [Abstract][Full Text] [Related]
15. Delta9-tetrahydrocannabinol-induced apoptosis in Jurkat leukemia T cells is regulated by translocation of Bad to mitochondria.
Jia W; Hegde VL; Singh NP; Sisco D; Grant S; Nagarkatti M; Nagarkatti PS
Mol Cancer Res; 2006 Aug; 4(8):549-62. PubMed ID: 16908594
[TBL] [Abstract][Full Text] [Related]
16. The survival function of the Bcr-Abl oncogene is mediated by Bad-dependent and -independent pathways: roles for phosphatidylinositol 3-kinase and Raf.
Neshat MS; Raitano AB; Wang HG; Reed JC; Sawyers CL
Mol Cell Biol; 2000 Feb; 20(4):1179-86. PubMed ID: 10648603
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways involved in the anti-apoptotic effect of 1,25-dihydroxyvitamin D3 in primary human keratinocytes.
De Haes P; Garmyn M; Carmeliet G; Degreef H; Vantieghem K; Bouillon R; Segaert S
J Cell Biochem; 2004 Nov; 93(5):951-67. PubMed ID: 15389877
[TBL] [Abstract][Full Text] [Related]
18. Nephrin, a transmembrane protein, is involved in pancreatic beta-cell survival signaling.
Kapodistria K; Tsilibary EP; Politis P; Moustardas P; Charonis A; Kitsiou P
Mol Cell Endocrinol; 2015 Jan; 400():112-28. PubMed ID: 25448064
[TBL] [Abstract][Full Text] [Related]
19. Differential sensitivity to apoptosis between the human small and large intestinal mucosae: linkage with segment-specific regulation of BCL-2 homologs and involvement of signaling pathways.
Gauthier R; Laprise P; Cardin E; Harnois C; Plourde A; Reed JC; Vézina A; Vachon PH
J Cell Biochem; 2001; 82(2):339-55. PubMed ID: 11527158
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin and UCN-01 synergistically induce apoptosis in human leukemia cells through a process that is regulated by the Raf-1/MEK/ERK, Akt, and JNK signal transduction pathways.
Hahn M; Li W; Yu C; Rahmani M; Dent P; Grant S
Mol Cancer Ther; 2005 Mar; 4(3):457-70. PubMed ID: 15767555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
